In the ranking of owner companies among 30 pharmaceutical companies, Eisai ranks 4th and Otsuka Holdings 2nd. The article states that the company ranked 1st is unknown.
The Diamond editorial department, working with the Family Business White Paper Planning and Editorial Committee, is publishing a pharmaceutical-industry version of a ranking that standardizes market capitalization and other measures for 1,885 listed owner companies. The article aims to clarify the ranking of owner companies among 30 pharmaceutical companies.
Many pharmaceutical owner companies have recently reported record-high revenue in their latest results. Ono Pharmaceutical and Eisai, in particular, achieved this in their latest full-year results. The article points to the importance of owner companies' financial resources and management decisions against the backdrop of substantial research and development expenses and capital investment.
The feature is said to rank 30 pharmaceutical owner companies using indicators including market capitalization, operating profit margin, and ROA. The company ranked 1st appears to be well ahead of the others because of the strength of its financial indicators. Although the article does not identify the company by name, it presents a picture of the leading company in the industry.
Charts and related articles are also included, allowing readers to follow the overall picture of owner companies in the pharmaceutical industry and the trends among the leading companies.